In the four clinical trials completed so far, people treated with this medication lost on average 10 to 17 percent of their body weight, which is a huge step forward compared with all other medications currently available to treat obesity, says Lingvay
This approach aligns well with the appetite-suppressing effects of GLP-1 medications, which naturally reduce hunger and promote earlier satiety
Consider discussing the pill with your doctor if: You have a strong aversion to self-injecting You travel frequently and prefer not to manage refrigerated medications Your morning schedule allows for a 30-minute fasting window before eating You do not take other morning medications that would complicate the timing You are not breastfeeding The injection may remain the better fit if you have MASH (metabolic dysfunction-associated steatohepatitis), since that indication was studied specifically with the injectable form, or if your morning routine makes consistent fasting difficult
There Is No One-Size-Fits-All The question is not which medication is better, but: Which is more suitable for your body, goals, and medical profile Factors Doctors Consider At MedConsult Clinic, treatment decisions may depend on: Body composition and BMI Previous weight loss attempts Hormonal or metabolic factors Lifestyle and diet patterns Medical history Availability and Practical Considerations For expats, additional factors may include: Medication availability in Thailand Follow-up access and monitoring Travel plans and continuity of care Ultimately, the decision between tirzepatide vs semaglutide should be based on individual health goals and medical guidance
